Thursday, October 28, 2021

IP rights

PM calls for dismantling of patent protections in fight against pandemic

He says this will enable the production of cheaper, generic versions of life-saving medicines for critical diseases, from Covid-19 to HIV/AIDS.

Lifting IP rights for Covid vaccines – good or bad?

Concerns are raised about geopolitical interests, in addition to the unequal distribution of vaccine doses.

US backs plan to waive Covid-19 vaccine patents

US trade representative says while intellectual property rights for businesses are important, Washington 'supports the waiver of those protections for Covid-19 vaccines' in order to end the pandemic.

Waiving IP won’t boost vaccine production, says pharma group

Proponents of doing away with IP rights say more companies could produce the vaccine but IFPMA says the problem is logistics, not patents.

Other News